Last viewed: DGX

Prices are updated after-hours

DGX

Quest Diagnostics Incorporated

DGX | $126.98 -0.35% 0.0% 890K

|

Health Services

(0.0% 1d) (-1.3% 1m) (-11.2% 1y) (0.0% 2d) (0.0% 3d) (-0.9% 7d) (-0.93% volume)
Earnings Calendar: 2024-02-01
Market Cap: $ 14,101,899,134
http://www.questdiagnostics.com
Sec Filling | Patents | 47000 employees

(US) Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

clinical trials diagnostics information technology

add to watch list Paper trade email alert is off

Press-releases

Toxicology Testing Market size is set to grow by USD 32.58 billion from 2024-2028, High regulatory compliance in food industry boost the market, Technavio
Published: 2024-04-11 (Crawled : 02:00) - prnewswire.com
WAT | $304.18 -3.04% -0.72% 520K

|

Health Technology

| -9.61% | O: 1.5% H: 0.23% C: -1.07%
TMO | News | $547.25 -1.32% -1.51% 1.2M

|

Health Technology

| -5.21% | O: 0.07% H: 0.0% C: 0.0%
DGX | $126.98 -0.35% 0.0% 890K

|

Health Services

| -3.8% | O: -0.13% H: 0.2% C: -1.71%
LH M | $199.97 -0.97% 0.0% 680K

|

Health Services

| -4.41% | O: -0.61% H: 0.02% C: -0.68%
ABT | News | $105.9 -3.03% 0.38% 11M

|

Health Technology

| -2.91% | O: 0.43% H: 0.3% C: -0.18%
food set market

Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
Published: 2024-04-02 (Crawled : 15:30) - biospace.com/
DGX | $126.98 -0.35% 0.0% 890K

|

Health Services

| -5.45% | O: -0.13% H: 0.0% C: -1.72%
test genetic diagnostics

Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease
Published: 2024-03-26 (Crawled : 12:00) - biospace.com/
DGX | $126.98 -0.35% 0.0% 890K

|

Health Services

| -1.44% | O: 0.26% H: 0.1% C: -0.58%
disease test blood alzheimer's imaging study

Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024
Published: 2024-03-19 (Crawled : 22:00) - biospace.com/
DGX | $126.98 -0.35% 0.0% 890K

|

Health Services

| -0.56% | O: 0.12% H: 1.28% C: 0.59%
first diagnostics financial results

Global Respiratory Syncytial Virus Diagnostics Market Report 2024-2029: Rising Healthcare Expenditure, Technological Innovations, and Increased Incidence of RSV Fueling Growth
Published: 2024-03-05 (Crawled : 05:00) - prnewswire.com
TMO | News | $547.25 -1.32% -1.51% 1.2M

|

Health Technology

| -5.91% | O: -0.09% H: 0.86% C: 0.6%
DGX | $126.98 -0.35% 0.0% 890K

|

Health Services

| 1.68% | O: 0.38% H: 0.69% C: -1.01%
NVS | News | $93.08 -0.13% 0.13% 1.1M

|

Health Technology

| -8.72% | O: 0.32% H: 0.22% C: -0.2%
BIO | $290.86 -0.65% -2.72% 140K

|

Health Technology

| -12.53% | O: -0.53% H: 1.08% C: -0.59%
ABT | News | $105.9 -3.03% 0.38% 11M

|

Health Technology

| -8.93% | O: 1.6% H: 0.0% C: 0.0%
QDEL | News M | $38.71 -3.95% -4.19% 580K

|

Health Technology

| -12.68% | O: 0.18% H: 1.13% C: -3.31%
report respiratory global rsv virus diagnostics growth market

Next Generation Sequencing Services Markets, 2030 - Substantial Growth with Emphasis on Oncology and Reproductive Applications
Published: 2024-03-01 (Crawled : 19:00) - prnewswire.com
ILMN | $118.29 0.51% 0.52% 1.6M

|

Health Technology

| Email alert Add to watchlist
QGEN | $39.23 -0.23% 0.0% 800K

|

Health Technology

| Email alert Add to watchlist
NVTA | $0.019 0.0% 22M

|

Health Services

| Email alert Add to watchlist
PKI | $115.24 0.0% 1.6M

|

Health Technology

| Email alert Add to watchlist
QGEN | $39.23 -0.23% 0.0% 800K

|

Health Technology

| Email alert Add to watchlist
DGX | $126.98 -0.35% 0.0% 890K

|

Health Services

| Email alert Add to watchlist
SQL | $6.5991 -29.23% 22K

|

| Email alert Add to watchlist
services growth

Quest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare Conference
Published: 2024-02-23 (Crawled : 15:00) - prnewswire.com
CART A | $36.35 -1.62% -1.65% 1.8M

|

| 23.66% | O: 3.75% H: 3.84% C: -1.32%
DGX | $126.98 -0.35% 0.0% 890K

|

Health Services

| 1.66% | O: 0.32% H: 1.18% C: 1.07%
conference global diagnostics

Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Published: 2024-02-15 (Crawled : 12:00) - biospace.com/
DGX | $126.98 -0.35% 0.0% 890K

|

Health Services

| -0.23% | O: 0.22% H: 0.7% C: -1.77%
million cancer funding platform

Clinical Biomarkers Market Analysis and Forecast, 2023-2033 - Cancer Biomarkers to Witness the Highest Growth between 2023 and 2033
Published: 2024-02-13 (Crawled : 03:00) - prnewswire.com
TMO | News | $547.25 -1.32% -1.51% 1.2M

|

Health Technology

| 0.07% | O: -0.99% H: 0.88% C: -0.52%
DGX | $126.98 -0.35% 0.0% 890K

|

Health Services

| -1.99% | O: 0.01% H: 0.55% C: -1.66%
QGEN | $39.23 -0.23% 0.0% 800K

|

Health Technology

| -10.47% | O: -1.64% H: 0.58% C: -0.56%
BIO | $290.86 -0.65% -2.72% 140K

|

Health Technology

| -10.28% | O: -1.32% H: 0.37% C: -1.83%
BDX | $232.21 0.52% 0.0% 1.5M

|

Health Technology

| -5.08% | O: 0.04% H: 0.72% C: -1.81%
A | $134.55 -1.65% -1.15% 1.8M

|

Health Technology

| 2.82% | O: -2.03% H: 1.0% C: -0.44%
ABT | News | $105.9 -3.03% 0.38% 11M

|

Health Technology

| -3.23% | O: 0.94% H: 0.0% C: 0.0%
QGEN | $39.23 -0.23% 0.0% 800K

|

Health Technology

| -10.47% | O: -1.64% H: 0.58% C: -0.56%
MYGN | News F | $18.64 -1.48% -1.39% 550K

|

Health Technology

| -19.13% | O: -3.99% H: 1.49% C: -3.71%
ILMN | $118.29 0.51% 0.52% 1.6M

|

Health Technology

| -15.48% | O: -2.48% H: 1.08% C: -2.01%
CNTG | $0.48 -0.02% 0.14% 17K

|

Commercial Services

| -50.25% | O: 2.59% H: 0.0% C: -11.11%
cancer biomarkers growth market

First PFAS "Forever Chemicals" Consumer-Initiated Blood Test with Physician Consult Launches on questhealth.com
Published: 2024-02-12 (Crawled : 13:00) - prnewswire.com
DGX | $126.98 -0.35% 0.0% 890K

|

Health Services

| 0.54% | O: -0.21% H: 2.9% C: 2.79%
first test blood

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001022079-24-000089	4	2024-03-28	2024-03-26	Sell	F	170	5433
0001022079-24-000088	4	2024-03-28	2024-03-26	Sell	F	114	15981
0001022079-24-000085	4	2024-03-01	2024-02-28	Sell	F	105	16082
0001022079-24-000085	4	2024-03-01	2024-02-28	Sell	F	228	16187

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

57%

43%

Top 10 Gainers

INVO | $1.82 139.47% 56.82% 220M

|

Health Technology

SINT | $0.0373 62.88% 37.26% 460M

|

Health Technology

WISA 4 | $9.25 51.64% 34.27% 64M

|

Electronic Technology

EDBL | News | $6.66 46.37% 32.39% 13M

|

GCTK | $0.715 36.27% 26.62% 600K

|

TCON | $2.29 33.92% 26.61% 1.8M

|

Health Technology

TIRX | $0.4848 7.49% 24.58% 5.9M

|

SRFM 4 | $0.3859 -12.3% 23.84% 660K

|

KZIA | $0.3442 18.28% 23.42% 290K

|

Health Technology

VNDA | News | $5.24 29.38% 22.56% 24M

|

Health Technology

Last 48 Hours Insiders Buying

IZEA | $2.53 1.2% -2.4% 8.7K

|

Technology Services

| 00:00
RKT P 383 | $11.38 -0.52% 1.58% 1.4M

|

| 22:30
CTRN P 18090 | $22.37 -1.41% -1.02% 55K

|

| 22:00
BRN P 10650 | $2.79 2.2% 0.0% 35K

|

Energy Minerals

| 21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M

|

Health Technology

| 16:30
RMCF | $3.53 -3.16% -3.85% 3.8K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar